Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 2

Results For "UBE"

206 News Found

HearClear partners with Neuberg Diagnostics to create integrated hearing care ecosystem
Healthcare | August 23, 2024

HearClear partners with Neuberg Diagnostics to create integrated hearing care ecosystem

The brand will establish an integrated hearing care ecosystem at Neuberg Diagnostics centers across the length and breadth of the country


Bayer announces positive topline results for Nubeqa from Phase III trial in men with mHSPC
Diagnostic Center | July 23, 2024

Bayer announces positive topline results for Nubeqa from Phase III trial in men with mHSPC

Phase III ARANOTE trial met primary endpoint, significantly increasing radiological progression-free survival (rPFS) with NUBEQA plus androgen deprivation therapy (ADT) compared to placebo plus ADT


UBE announces Phase I clinical trial for SSAO/VAP-1 licensed exclusively to Novo Nordisk
Diagnostic Center | February 15, 2024

UBE announces Phase I clinical trial for SSAO/VAP-1 licensed exclusively to Novo Nordisk

MASH is a chronic and progressive liver disease characterised by fat accumulation and inflammation in the liver,


AIIA initiates training programme on latent tuberculosis infections
Healthcare | December 02, 2023

AIIA initiates training programme on latent tuberculosis infections

The workshop is specially curated for Ayurvedic medical officers from Delhi and Haryana


Mankind Pharma appoints Prateek Dubey as President - Global CHRO
People | October 16, 2023

Mankind Pharma appoints Prateek Dubey as President - Global CHRO

Prateek has more than 23 years of rich experience in Human Resource


IMI 5.0 campaign with special focus on improvement of Measles and Rubella vaccination coverage
Policy | October 13, 2023

IMI 5.0 campaign with special focus on improvement of Measles and Rubella vaccination coverage

Over 34 lakh children and 6 lakh pregnant women were administered vaccine doses during the first 2 rounds of IMI 5.0 campaign across the country


hubergroup India expands its support for rural healthcare
Healthcare | March 24, 2023

hubergroup India expands its support for rural healthcare

hubergroup’s two newly added medical vans are dedicated to dental and eye care


Merck and the Bill & Melinda Gates Medical Research Institute announce licensing agreement for tuberculosis antibiotic candidates
News | October 19, 2022

Merck and the Bill & Melinda Gates Medical Research Institute announce licensing agreement for tuberculosis antibiotic candidates

The TBDA is a collaboration established among biopharmaceutical companies, research organizations and universities to accelerate the discovery and development of novel therapeutic candidates against TB.


Lupin partners global Agencies to support tuberculosis prevention treatment
News | October 09, 2022

Lupin partners global Agencies to support tuberculosis prevention treatment

Through this agreement, Lupin will introduce two new formulations, a fixed-dose combination of Rifapentine + Isoniazid and Rifapentine 300 mg standalone tablets, at an affordable price